Cargando…
Anti PD-1 treatment increases [(18)F]FDG uptake by cancer cells in a mouse B16F10 melanoma model
BACKGROUND: Programmed cell death 1 (PD-1) inhibitors act as immune checkpoint inhibitors and are more effective for improving survival time with less toxicity as compared with conventional chemotherapies. In anti PD-1 therapy, it is important to evaluate metabolism in the cancer microenvironment, a...
Autores principales: | Tomita, Mayu, Yasui, Hironobu, Higashikawa, Kei, Nakajima, Kohei, Takakura, Hideo, Shiga, Tohru, Kuge, Yuji, Ogawa, Mikako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095935/ https://www.ncbi.nlm.nih.gov/pubmed/30117062 http://dx.doi.org/10.1186/s13550-018-0433-1 |
Ejemplares similares
-
Influence on [(18)F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumor
por: Tomita, Mayu, et al.
Publicado: (2020) -
Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO
por: Watanabe, Shiro, et al.
Publicado: (2019) -
Transferrin-based radiolabeled probe predicts the sensitivity of human renal cancer cell lines to ferroptosis inducer erastin
por: Shibata, Yuki, et al.
Publicado: (2021) -
Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019) -
Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo
por: Shibata, Yuki, et al.
Publicado: (2019)